Advanced Enzyme Technologies Q1 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
267.30
5.05 (1.93%)
5.05 (1.93%)Volume7.91 K
Updated: Fri 16 Oct, 2026 | 15:27:23
NSE
268.305.40 (2.05%)
5.40 (2.05%)Volume1.79 L
Updated: Fri 16 Oct, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹189.79 Cr.(2.08%)
- Operating Profit₹41.09 Cr.(-12.24%)
- Profit After Tax₹37.09 Cr.(-7.10%)
- Operating Margin21.65%(-14.03%)
Note: Comparison is on YoY basis
Quarterly - Advanced Enzyme Technologies Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 148.70 | 150.22 | -1.01% | 111.97 | 6.90% |
| Depreciation/ Amortization | 9.88 | 10.19 | -3.07% | 8.61 | 2.71% |
| Operating Income | 41.09 | 53.15 | -22.70% | 42.55 | -12.24% |
| Net Income | 37.09 | 42.96 | -13.66% | 34.15 | -7.10% |
| Other Operating Expenses Total | 44.58 | 41.27 | 8.03% | 34.45 | 12.24% |
| Net Income Before Taxes | 53.53 | 59.80 | -10.50% | 48.67 | -2.50% |
| Total Revenue | 189.79 | 203.37 | -6.68% | 154.52 | 2.08% |
| Selling/ General/ Admin Expenses Total | 44.55 | 41.94 | 6.23% | 34.66 | 12.18% |
| Diluted Normalized EPS | 3.31 | 3.83 | -13.57% | 3.05 | -7.28% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.